share_log

JMP Securities Reiterates Market Outperform on Benitec Biopharma, Maintains $4 Price Target

JMP Securities Reiterates Market Outperform on Benitec Biopharma, Maintains $4 Price Target

JMP Securities重申Benitec Biopharma的市場表現跑贏大盤,維持4美元的目標股價
Benzinga ·  2023/05/18 08:16

JMP Securities analyst Silvan Tuerkcan reiterates Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and maintains $4 price target.

JMP Securities分析師Silvan Tuerkcan重申,Benitec Biopharma(納斯達克股票代碼:BNTC)的市場表現跑贏大盤,並維持4美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論